AI-generated summary
The authors randomized 546 patients with acute low back pain and radiculopathy to nimesulide with active laser therapy, nimesulide alone, or nimesulide with placebo laser. Pain, lumbar movement, disability and quality of life all improved, with the largest gains in the active laser group, which the authors report as better improvement with laser as additional therapy.
- Participants
- 546
- Who or what was studied
- Patients with acute low back pain with radiculopathy
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The abstract reports only before-and-after outcomes within a single trial and does not state long-term follow-up or how the placebo laser blinding was verified.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Placebo-controlled, Visual analogue scale, Inflammation, Wavelength, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.